We now live in the era of "personalized cancer management." Enormous resource investments are being made for biomarker research for more targeted therapies.
Gastric cancer is approximately 10% of the total incidence rate of invasive cancer worldwide and is the second leading cause of cancer deaths.Despite of its
In China, great progress has commenced in anticancer drug research.New drugs and studies have been enhanced quantitatively and qualitatively.The China Food